Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
Reckon Ltd
ASX:RKN
|
AU |
|
Bleecker SA
PAR:BLEE
|
FR |
|
E
|
Eckert & Ziegler SE
XHAM:EUZ
|
DE |
|
A
|
Airship AI Holdings Inc
NASDAQ:AISP
|
US |
|
Billerud AB (publ)
STO:BILL
|
SE |
|
B
|
Boeing Co
XHAN:BCO
|
US |
|
MISC Bhd
KLSE:MISC
|
MY |
|
M
|
Minth Group Ltd
OTC:MNTHY
|
TW |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
E
|
Evoke PLC
OTC:EIHDF
|
GI |
|
V
|
Vinci SA
F:SQU
|
FR |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
HK |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
Airtificial Intelligence Structures
MAD:AI
|
ES |
Bankruptcy Probability
Recursion Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Recursion Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
2.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Recursion Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Recursion Pharmaceuticals Inc has total debt of 4.8m USD. This includes both short-term (0 USD) and long-term (4.8m USD) debt.
You can find a full breakdown on its Balance Sheet.
